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DEFINITIONS 
Investigator; Charles D. Ponte, B.Sc., R.Ph., 
Pharm.D. Candidate 
Pharmacist or Pharmacist Counselor: One of three 
decentralized pharmacists who provide pharma-
ceutical services for the fourth floor of 
University Hospital. All three were included 
in the study in counseling those patients 
assigned to the "counsel" groups. 
Study Groups: "Counsel" - a group of 25 patients 
who were to receive pharmacist discharge 
medication counseling in addition to the usual 
physician and/or nurse counseling. 
"No Counsel" - a group of 25 patients who would 
only receive the usual physician and/or nurse 
counseling concerning their discharge medication. 
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II. INTRODUCTION 
The overall objective of this research was to determine 
to what extent a pharmacist's counseling can influence a 
patient's ability to understand a physician's prescription 
instruction and overall knowledge of the drugs prescribed. 
This research was designed to determine whether pharmacist 
counseling could significantly improve upon the patient's 
knowledge and understanding gained from physician and/or nurse 
counseling. A total lack of patient counseling or insufficient 
counseling by health professionals may result in the following: 
(1) toxicity from the medication, (2) patient ignorance of 
possible adverse reactions and inability to deal with them 
effectively if they occur, (3) failure to achieve the desired 
therapeutic response,, (4) ignorance of the purpose for the 
medication or duration of treatment, (5) and/or insufficient 
knowledge on how to self-administer the drugs. 
A. Specific Study Objectives 
1. To compare the awareness of various aspects 
of drug therapy for two randomly selected 
groups of patients; 
a. patients who receive no drug counseling 
from a pharmacist prior to discharge; 
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b. patients who receive pharmacist counseling 
prior to discharge. 
Both groups of patients may also receive 
physician and/or nurse counseling prior to 
discharge. 
2. To assess the relationships between the patient's 
ability to understand a physician's prescription 
instructions and the following patient charac-
toiristics * 
a. patient age 
b. patient sex 
c. educational level' 
d. past experience with taking medication 
e. number of discharge medications 
III. BACKGROUND OF RESEARCH 
The amount of information about drugs has been 
increasing over the last few years. This may be one 
reason why many medications are probably not used in the 
1 2 
safest or most efficacious, convenient manner. ' There 
has also been a recent decreased emphasis on pharmacology 
3 4 
education at some medical schools ' and a dependence 
upon pharmaceutical promotional sources for drug infor-
mation.5 These may often place the health professional 
in a difficult position. The information he gives to a 
patient may not be accurate or complete enough to maximize 
the patient's understanding of or compliance with the 
prescribed medication regimen. 
Tradidional Pharmacy services have consistently 
involved providing drugs that physicians have ordered for 
patients. Pharmacists have typically been isolated from 
patients and have seldom been directly involved in patient 
care. However, pharmacists have important skills to contri 
bute to clinical medicine. They are scientifically trained 
licensed professionals with five or more years of college 
work involving in-depth study of all areas of drug use. 
Their training places particular emphasis on pharmacology, 
pharmacotherapeutics, pharmacokinetics, drug information 
retrieval and evaluation, in addition to experience in a 
variety of clinical settings ranging from hospitals to 
community pharmacies. 
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Despite this training, pharmacy is falling short of 
its full potential. In 1976, the Study Commission on £ 
Pharmacy viewed the profession as a knowledge system 
which produces a service. In the opinion of the Commission, 
The knowledge system which is pharmacy and the people 
called pharmacists who are deeply involved in that 
system should move to meet the health care system's 
unmet needs which involve drugs and drug information. 
These unmet needs for the most part are not needs 
for drug products but rather for drug information 
required by physicians and nurses and particularly 
by patients, (p. 137) 
Thus, it seems reasonable that by promoting more rational 
utilization of drugs and communicating drug information to 
patients and health professionals, pharmacists can begin to ex-
pand their responsibilities and assume an important role 
in enhancing patient care to assure the maximum effectiveness 
and safety of drug therapy. 
The problem of patient compliance has been studied 
Often.7-" The incidence of patient noncompliance determine* 
7 14 
from studies ranges from 4 to 100 percent. ' In view 
of the wide range for noncompliance rates, an adequate 
definition of compliance is lacking. Although studies have 
indicated a wide variation in the degree of noncompliance, 
in most studies at least a third of the patients failed to 
15 
comply with the prescription instructions. The type of 
action most commonly identified as evidence of noncompliance 
6 
is the omission of doses of a medication. Other evidence 
of noncompliance includes taking a drug for the wrong 
purpose, errors of dosage and errors in the time of admin-
istration of the drug. 
Reviews of these studies and the impact of patient 
failure to comply (intentional or accidental) with the 
1 15 
physicians directions have been done by Hussar and Boyd. 
It has been suggested that the pharmacist should be the 
health care resource who should take responsibility for 
dealing with this widespread phenomenon. The pharmacist is 
the last person on the health care team to have contact with 
the patient before he becomes independent in the self-
administration of his medication. The pharmacist is in a 
unique position to reinforce the physician's instructions 
and answer any patient questions about his medication. 
Although there are many factors which influence 
7 
medication compliance, errors made m dosage and frequency 
of medication administration secondary to patient confusion 
over prescription instructions have not been sufficiently 
17—18 
studied. In a study undertaken by Mazzullo and 
17 
Lasagna, there were frequent errors of interpretation of 
prescription instructions even when the instructions were 
not ambiguous. For example, patients were asked to interpret 
a prescription which read, "Tetracycline, 250 mg every six 
7 
hours." Only 36 percent of 6 7 study patients indicated that 
they would take the "drug around the clock every six hours 
for a total of four doses per day. If patients understand 
their medication dosing instructions and have some basic 
knowledge of the drugs they are taking, compliance may 
be enhanced. 
There are many points in the present health care 
delivery system where prescription instructions can be 
given, explained and reinforced to ensure proper self-
administration of medications by patients. This study was 
designed to determine whether pharmacist counseling of hos-
pitalized patients can significantly improve the patient's 
ability to understand how to take a particular medication 
and basic knowledge of a drug prescribed by physicians 
upon discharge from the hospital. 
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IV. STUDY METHODS 
A. Study Site Characteristics 
The study was conducted at the University of Utah 
Hospital. The hospital is a 318-bed referral center 
located in Salt Lake City, Utah and serves the 
intermountain west. 
Patients admitted to the fourth floor of University 
Hospital participated in the study. The floor has 56 
internal medicine beds, a seven-bed coronary care unit 
and a 15-bed clinical research center. The Department 
of Internal Medicine employs 34 medical residents which 
includes first through third year residents, who have 
responsibility for the patients on the fourth floor. 
There are four Internal Medicine teams responsible for 
patients on the floor. A team consists of a second or 
third year medical resident, several first year residents 
(interns), medical students, clinical pharmacy faculty 
and Pharm.D. candidates and, at various times during 
the school year, senior pharmacy students. 
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B. Decentralized Pharmacy Services at University Hospital 
Hospital-wide implementation of decentralized 
pharmacy services was approved by hospital administration 
and the pharmacy and therapeutics committee in July 1978. 
By October 1978, all inpatient care areas of the hospital 
were decentralized without the addition of satellite 
pharmacies on each floor. 
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Planning for decentralized pharmacy services began 
early in 1978. Hospital-wide unit dose drug distribution, 
intravenous admixture, drug information and clinical 
pharmaceutical services were already being provided. 
Centralized unit dose drug distribution had been in effect 
at the hospital since 1977. In this situation, the pharmacy 
is usually distant from other professional services 
and patient floors. Pharmacists practicing in central-
ized pharmacies are often isolated from patients and other 
health care professionals. 
With decentralized pharmaceutical services, drug orders 
are not sent to the central pharmacy via pneumatic tubes 
or messengers. When a physician writes a medication 
order, the pharmacy copy is removed by a ward clerk who 
enters the order onto the medication administration record-
patient profile. This copy is placed in the pharmacy 
order box at the nursing unit. The pharmacist 
orders prior to dispensing the required medication and 
is available for new, emergency, leave-of-absence and 
discharge medication orders. 
The pharmacist checks for new orders several times a 
day and can be contacted via a pocket voice-pager for 
orders or other needed services. Discharge and leave-of-
absence medication orders are filled by the pharmacist, 
who subsequently provides appropriate medication counseling 
to the patient. 
Job responsibilities for the decentralized pharmacists 
include patient education, clinical services and dis-
tributive functions (see Appendix A). 
C. Patient Medication Counseling by Health Professionals 
The Department of Pharmacy Services encourages 
physicians to write prescriptions 24 hours before the 
patient is discharged. Most discharge prescriptions are 
written the morning of the patient's discharge. 
The discharge prescriptions are written in the 
physician's orders section of the medical record. The 
discharge medication orders are periodically picked-up 
by either a decentralized pharmacist or a pharmacy 
technician. 
The pharmacist fills the discharge orders in the 
Outpatient Pharmacy located on the first floor of 
University Hospital. The pharmacist or pharmacy tech-
nician brings the prescription to the floor and the 
pharmacist goes to the patient's room where the discharge 
counseling takes place. 
The pharmacist is one of several individuals who may 
counsel patients concerning discharge medications. 
Physicians may discuss discharge medications with patients 
prior to or after the pharmacist had talked to the patient. 
Medications are often discussed with the patient by the 
11 
physician during morning rounds and at other times 
during the day. 
Nurses also counsel patients regarding their discharge 
medication. Nurses may also counsel patients about medi-
cation during the patients' hospital stay. 
The nature of the information which is provided by 
pharmacists, physicians and nurses is not really known. 
Studies to assess the information provided to patients by 
these health professionals have not been performed to 
date as can be determined by this author. 
D- Subjects and Study Design 
Individuals admitted to the Internal Medicine service 
at the University of Utah Medical Center Hospital between 
December 10, 1979 and January 11, 1980 were eligible for 
participation in the study. Patients were excluded from 
the study if they: 
1. refused to participate 
2. were hearing and/or speech impaired 
3. had taken the prescribed medication within 
the last year 
4. were non-English speaking patients 
5. were discharged to a nursing home and not res-
ponsible for self-administration of their medication 
6. were discharged with more than 6 new prescriptions 
12 
7. were younger than 18 years or older than 75 
years of age 
Reasons for these exclusion criteria can be found 
in Appendix B. 
1. Patient Assignment to Study Groups 
Fifty patients were randomly assigned to two 
groups of patients (25 each) by the toss of a 
coin. The coin was flipped until 25 patients had 
been assigned to one of the groups. The remainder 
of the patients automatically entered the other 
group. 
The randomization schedule was not known 
by the investigator during the course of 
the study. It was kept on the master 
medication cart used by the decentralized pharma-
cists on the fourth floor to transport medication 
drugs to the patient-care areas. 
2. Knowledge of Patient Discharges 
The investigator needed to know what patients 
were to be discharged. Patient discharges were 
ascertained in one of three ways. First, the inves-
tigator periodically checked with the unit clerk 
to determine discharges. Secondly, the investigator 
could be contacted via a voice-pager by the 
decentralized pharmacist or pharmacy technician. 
Lastly, the investigator could be contacted via a 
general hospital page. 
Following notification of a planned patient discharge, 
the investigator would review the patient's chart to 
determine patient eligibility for the study. 
If the patient was determined to be eligible, the 
investigator contacted the pharmacist-counselor 
and indicated that the patient was eligible. The 
pharmacist-counselor assigned the patient to one 
of the two study groups without informing the inves-
tigator of the group assignment. 
The discharge medication orders were filled 
by the decentralized pharmacist who then gave the 
prescriptions to the patient in his room. 
3. Pharmacist-Counselors 
Three staff pharmacists participated in the 
study. All three pharmacists were assigned to the 
fourth floor of University Hospital. 
Prior to the start of the study, a brief meeting 
was held to inform the pharmacists and technicians 
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about the study. Only the mechanics of the study 
were discussed. No mention was made of the title 
or purpose of the study or of the assessment instru-
ments . 
The pharmacists and technicians were instructed to 
assign patients for the study according to the 
assignment sheet kept on the master medication cart. 
If a patient was to be counseled, he would receive 
whatever counseling the pharmacist traditionally gave 
patients. If a patient was not to be counseled, 
the pharmacist simply dispensed the discharge 
prescriptions to the patient. There 
were no guidelines given as to how patients were to 
be counseled, what information was to be provided 
and what methods were to be utilized in the trans-
mission of information to the patients. 
4. Physician/Nurse Study Awareness 
Physicians and nurses had no knowledge as to 
which patients were counseled by a pharmacist. They 
were not informed of the starting date of the study nor 
the nature of the study. 
E. Study Instrument (see Appendix C) 
A three page questionnaire form was developed to col-
lect data for the study. The questionnaire comprised 11 
15 
questions used to assess: (1) specific patient information; 
and (2) knowledge concerning how to take the medication 
prescribed and general information about the drug assessed. 
Several of the questions were designed to determine 
individual patient characteristics and conditions that 
may influence the patient's interpretation of the medi-
cation instructions. The reasons for including each of 
the 11 questions may be found in Appendix D. Assessment 
criteria for question 10 (see Appendix E) were developed 
so that patient responses were consistently rated by the 
investigator as either correct or incorrect in an effort 
to limit investigator bias and increase reliability of rating. 
F. Data Collection Procedure 
When the investigator determined that a patient was 
eligible for participation in the study,* the pharmacist-
counselor assigned that patient to either the "counsel" 
or the "no-counsel" group. After filling the discharge 
medications, the pharmacist would return to the floor and 
depending on the patient's study group assignment, would 
either counsel the patient or only leave the medications 
with the patient. 
* If the patient had been given more than one new drug, the 
investigator listed them in the order they were written 
in the original physician orders in the patient's chart. A 
single die was tossed and the number which came up was 
the number of the drug on the list which would be assessed. 
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The investigator proceeded to the patient's room after 
the discharge medications had been given to the patient. 
The patient was given a consent form to read and sign 
(see Appendix P). A copy was given to the patient to take 
home with him. 
The patient was informed by the investigator that the 
conversation would be taped on a cassette-recorder. The 
tape recordings were later used to assess the reliability 
of the investigator. The time involved in conducting the 
interview was cl 1 SO discussed with the patient. 
The investigator then asked the patient the questions 
found on the two page assessment form. The investigator 
clarified questions but gave no prompts or suggested 
answers. 
The investigator counseled the patient on all discharge 
medications after the interview, if the patient had not 
been counseled by a pharmacist previously. Misinterpre-
tations or misunderstandings by the patient about the 
medications were rectified by the investigator. 
All the patient interviews were conducted in the hospital 
room. The patient's family was allowed to remain in the room 
during the interview. 
G. Investigator and Questionnaire Reliability Assessment 
The information obtained from the study would be mean-
ingless if the reliability of the data collected was low. 
In order to assess the reliability of the instruments used 
in the study, reliability studies were undertaken. 
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Patient reliability in answering questions was 
assessed in the following way. A questionnaire was 
developed by the investigator which was composed of six 
questions (see Table 1). The questions were similar to 
the questions used in the actual study (see Appendix G). 
A pilot study involving 20 patients was conducted at 
Holy Cross Hospital (October 10, 1979 to October 17, 
1979}. The hospital is a 350-bed private, community 
ho spital in Salt Lake City. 
Upon arrival at the admitting office, each new 
patient was asked to complete a questionnaire. Several 
days after admission (1-6 days), an individual from 
the Admitting Office saw the patient on the ward and 
verbally asked the same questions found on the question-
naire. Product Moment Correlation was used to compare both 
sets of answers (see Table 2 - Results) . 
The reliability with which the investigator applied 
the assessment criteria to the patient responses to 
the study questions was also assessed. The investigator 
taped each of his conversations with the patients. Thirty-
six patients were taped. Fourteen patients were not 
taped due to either the investigator failing to record 
the conversation or equipment malfunction. A sub-sample of 
10 tapes was randomly chosen and independently rated. 
TABLE 1 
Pilot Study - Holy Cross Hospital: Questions Asked 
To Ascertain Patient Reliability 
Question: 
1. How many medications have you been taking on a regular 
basis at home? 
2. How many different medications have you taken at 
home within the last year? 
3. Are you allergic to any medications? yes ( ) no { ) 
If yes, what medications {list all). 
4 . How many vitamin pills do you take per day? 
5. In which of these places do you keep prescription 
medications? 
medicine cabinet in bathroom handbag 
drawer in bedroom bureau wallet 
kitchen cupboard automobile 
other, please specify 
6. In which of these places do you keep non-prescription 
medications? 
medicine cabinet in bathroom handbag 
drawer in bedroom bureau wallet 
kitchen cupboard automobile 
other, plea specify 
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The rater was trained by the investigator. The 
rater was informed about the study protocol, the study 
philosophy of the investigators and other information 
which the rater would need. The assessment criteria were 
discussed with the rater in detail. 
The investigator informed the rater of the drug 
name, strength, quantity and directions for each of the 
ten tapes chosen. The indication for the medication was 
also told to the rater. The rater was also given basic 
information about the drug (i.e., side-effects, inter-
actions and special precautions). 
The rater listened to each tape and rated only question 
10 (12 sub-questions) of the assessment form. Only 
question 10 was rated because the assessment criteria only 
applied to the 12 sub-questions. After all 10 tapes were 
rated, the answers of the investigator and the rater 
were compared. 
II. Data Analysis 
Data generated from the interviews was subjected to 
a Chi Square Analysis ( ®< = 0.05) to determine any 
difference between both groups of patients in their 
understanding of the prescription instructions and 
knowledge of the medication. 
Correlational Analysis was undertaken to determine 
if individual patient characteristics were related 
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to their interpretation of the prescription instruc-
tions and knowledge of the medication. 
I. Potential Risks and Benefits 
The study involved no invasive procedures and, there-
fore, the potential physical risks to the patient were 
minimal. The study did contain the following benefits: 
If it was determined after the interview that there was 
significant misinterpretation or misunderstanding of 
either the drug or the prescription instructions by 
the patients, they were corrected so that the patient 
might achieve the maximum benefit from the intended therapy. 
RESULTS 
A. Reliability Assessment 
Patient reliability in answering questions was assessed 
by comparing two sets of patient responses to a question-
naire comprised of six questions. Questions similar to 
those used in the actual study were used. The results 
are found in Table 2. 
The investigator reliability assessment involved 
comparing the answers to question 10 (12 sub-questions) 
of the rater and the investigator. Both sets of responses 
agreed exactly (see Table 3). Consistency in application 
of the assessment criteria to the patient responses was 
noted. 
TABLE 2 
Percent Agreement and Product - Moment Correlational 
Analysis* of Pilot Study Questions Holy Cross 
Hospital (October 10-17, 1979) 
Question: 
1. How many medications have you been taking on a regular 
basis at home? 
h =0.83 
2 . How many different medications have you taken at home 
within the last year? 
f =0.72 
3. Are you allergic to any medications? 
100% Agreement*** 
4. How many vitamin pills do you take per day? 
• =0.97 
*Questions 1, 2, and 4 
** when f = 1,00; Perfect Agreement 
*** Percent Agreement Statistical Analysis 
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TABLE 3 
Investigator Reliability Assessment: Comparison of Rater 
vs. Investigator Responses to a Sub-Sample of 
10 Study Patients (Counseled by Pharmacist - 7, 
Not Counseled - 3) 
Comparison of Rater vs. Investigator Answers 
Question 10* Yes No Correct Incorrect 
1 7 7 3 3 
2 6 6 4 4 
3 9 9 1 1 9 9 1 1 
4 8 8 2 2 
5 8 8 2 2 
6 6 6 4 4 
7 6 6 4 4 
8 2 2 8 8 10 10 0 0 
9 2 2 8 8 10 10 0 0 
10 3 3 7 7 10 10 0 0 
11 4 4 6 6 10 10 0 0 
12 4 4 6 6 10 10 0 0 
Colums - Left-hand figures = Investigator 
Right-hand figures = Rater 
*Question 10 (12 parts) was assessed since this was the 
only question which required use of the assessment criteria. 
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B. Patient Characteristics 
There was no significant difference (Chi Square -
p ^  0.10) noted between the "counsel" vs. "no-counsel" 
patient groups involving age, sex or educational level 
( 56 C Table 4) . 
C. Prior Experience with Medication 
The average number of medications taken at home 
indicated by the patients (Question 4) was 1.9 2 and 2.00 
for the "counsel" and no-counsel" groups, respectively. 
One patient in the "no-counsel" group did not answer 
the question. 
The average number of different medications taken at 
home within the past year by patients (Question 5) was 
2.20 and 2.96 for the counsel and no-counsel groups, 
respectively. Four patients in the "counsel" group did 
not respond to the question and two patients in the 
"no-counsel" group did not respond to the question. 
There was a difference between questions 4 (How many 
medications have you been taking on a regular basis at 
home?) and 5 (How many different medications have you 
taken at home within the last year?) and the "counsel" 
"no-counsel" groups (Student t-test p ^.001). 
D. Miscellaneous 
The average number of prescriptions given patients 
to take home with them (Question 6) was 2.31 and 3.17 for 
24 
TABLE 4 
Age, Sex and Education Characteristics of Study Patients 
Ave Ave Educ 
Age Range Male Female Level Range 
25 patients - 50.5 22-72 10 15 13.6 8-16.5 
no counsel 
25 patients - 51.3 18-75 10 15 13.2 8-16 
counsel 
No counsel -
Male 52.6 36-70 - - 12.8 8-16 
Female 49 22-72 - 14 12-16.5 
Counsel -
Male 49 18-74 - - 13.6 11.5-16 
Female 52.8 25.75 - - 12.9 7.5-16 
Educational Level - Graduate Studies = 16 years 
25 
the "counsel" and "no-counsel" groups, respectively. 
One patient in each group did not respond to the question. 
The average number of prescriptions given to patients to 
take home and which they had not taken before (Question 7) 
was 1.86 and 1.30 for the "counsel" and "no-counsel" 
groups, respectively. One patient in the "no-counsel" 
group did not respond to the question. There was no 
statistically significant difference between the "counsel" 
and "no-counsel" groups for Questions 6 and 7 (p^ 0.10). 
Histograms have been provided which depict the data 
for Question 4 through 7 (see Figures 1-4) . 
Question 8 determined the physicians who were taking 
care of the patients. Since the question only gave 
insight into how well the patients could remember the 
physicians'names, this knowledge would add little to the 
overall purpose of this project. Four of the fifty 
patients did not know the name of the physician taking 
care of them. No further analysis of these data was 
undertaken. 
Question 9 determined the adequacy of counseling 
perceived by the patients regarding their discharge 
medications. The data were analyzed and are presented 
in Table 5. 
Eighty-two percent of the patients indicated that 
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Question 7 How many medications have you been given 
to take home with you which you have 
never taken before? 
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TABLE 5 
Adequacy of Medication Counseling Perceived by 50 Patients 
Question 9 - How adequate was the counseling you received 
regarding your discharge medications? 
Response # of Responses Percentage of Total 
1. No counseling 5 10 
2. Some counseling 
but very inadequate 
1 2 
3. Barely adequate 3 6 
4. Rather good 
counseling 
13 26 
5. Very thorough and 
adequate 28 56 
TOTAL 50 100 
or "very thorough and adequate." Eighteen percent 
of the patients indicated that the counseling received 
was inadequate. Out of this 18 percent, 10 percent 
(five patients) indicated that none had counseled them; 
neither a pharmacist, physician or nurse. 
The adequacy of counseling noted by the patients 
was further analyzed (Table 6). The adequacy ratings for 
physicians, pharmacists and nurses were assessed. 
Question 6 (How many medications have you been given 
to take home with you?) and Question 10 (Can you give me 
a list of all the medications that you will be taking 
at home after you are discharged from the hospital?) 




Counseling Adequacy Ratings for Physicians, Pharmacists, 
and Nurses as Determined from Question 9 




Physician & Nurse 2 
Physician & Pharmacist 2 
None 10 
"I don't know" 1 
TOTAL 50 
* Ratings: 
1. No counseling 
2. Some counseling but very inadequate 
3. Barely adequate 
4. Rather good counseling 
5. Very thorough and adequate 
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Question 6 should be answered with a numerical response 
(1, 2, 3...) and Question 10 should be answered with 
the names of the discharge medications (Lasix, Digoxin...) . 
If one converts the answers of Question 10 to numbers, 
then one could compare both answers and test for 
correspondence between the numerical answers. Product-moment 
correlational analysis was applied to the data. Good 
C CD IT 61 ct til. on was noted (r = 0.8 3). The answers of 29 
patients to Questions 6 and 10 agreed perfectly. 
Eleven patients gave different answers to each question 
and 10 patients gave no answer for question 10 despite 
answering Question 6. 
Eleven patients stated conflicting answers regarding 
who counseled them about their discharge medications. 
Eight patients stated that a physician had counseled them 
but actually a pharmacist had counseled the patient. In 
one case where a pharmacist had counseled the patient, 
the patient could not relate who counseled him. One 
patient was counseled by a nurse but the patient stated 
that no one had counseled him. One patient was counseled 
by a pharmacist but indicated that no one had counseled 
him. 
The results from Question 10 (12 parts) were compiled 
for each group of 25 patients and are presented in Table 7. 
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TABLE 7 
Comparison of Patient Responses and Investigator 
Ratings for Question 10 
Sub-
question yes no correct incorrect 
1 22 22 3 3 
2 11 14 14 11 
3 19 23 6 2 24 25 1 0 
4 18 20 7 5 
5 18 21 7 4 
6 20 19 5 6 
7 13 13 12 12 
8 3 4 22 21 25 24 0 1 
9 3 6 22 19 24 21 1 4 
10 4 9 . 21 16 25 24 0 1 
11 8 12 17 13 23 24 2 1 
12 6 11 19 14 25 24 0 1 
Colurns - Left-hand figures = "No counsel" group 
Right-hand figures = "counsel" group 
NOTE: YES/NO refers to those questions requiring the patient 
to respond with a yes or no to the investigator (i.e., will 
you be taking this medication by mouth/}. 
CORRECT/INCORRECT - the investigator rated each patient 
response as being correct or incorrect based on predetermined 
assessment criteria (see Appendix F). 
The numbers in each column represent the total number of 
responses for a particular question. 
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Each of the twelve sub-questions of question 10 
was analyzed by simple Chi Square Analysis to determine 
if the groups differed. No difference was found between 
the "counsel," "no-counsel" patient groups on any of 
the twelve sub-questions (p>* 0.10) . 
A list of the drugs assessed during the study can 
be found in Appendix H. The list of drugs was divided 
into drug classes in an attempt to ascertain the class 
of drug encountered the most frequently during the 
four weeks of the study. The top three drug classes 
encountered were analgesics, antibiotics and diuretics, 
in that order. The analgesics represented 16 percent 
of the total drugs encountered; antibiotics represented 
10 percent and the diuretics 8 percent. The percentage 
of analgesics found during the actual study was nearly 
the same as was found during a fourth floor pilot study 
(see Discussion) where analgesics also represented the 
largest drug class encountered, representing 17 percent 
of the total drugs assessed, followed by cardiac agents 
(13 percent) and antihypertensives (12 percent) . 
VI. DISCUSSION 
The intent of the study was to determine if pharmacist 
counseling had any effect on patients' ability to understand 
prescription directions and their overall knowledge of the drugs 
prescribed. The effect of pharmacist counseling was measured 
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against the usual counseling provided by the physician and/or 
nurse to the patient. The results indicated that there was 
no difference in the knowledge gained or awareness of the 
prescription directions by those patients who received 
pharmacist counseling versus those who received no pharmacist 
counseling. 
A. Analysis of Selected Questions 
1. Question 1 through 3 
The random assignment of patients into the two 
study groups resulted in groups that were nearly 
identically matched for certain patient character-
istics such as sex, age and education. Our study 
results indicate that no relationship could 
be found between the patients ability to understand 
a physician's prescription instructions and the 
patient variables of age, education and past 
experience with taking medication. Although we did 
not investigate the relationship between educational 
level and medication knowledge, several investigators 
have reported little association between education 
and medication compliance. Age has also been found 
to have little if anything to do with medication 
knowledge or compliance. ^  ' ^ 
2 . Question 5 
In a 1965 nationwide survey by the National 
22 
Center for Health Statistics (NCHS), males 65 
years and older acquired an annual average of 9.3 
prescriptions compared to 3.1 prescription by those 
under 65 years. Females 65 years and older acquired 
13.1 prescriptions compared to 4.8 prescriptions 
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for their younger counterparts. In this study 
population, males 65 years and older acquired an 
annual average of 3.4 prescriptions compared to 2.3 
by those under 65 years. Females 65 years and older 
acquired 3.7 prescriptions versus 2.8 prescriptions 
for their younger counterparts (see Appendix I) . 
The discrepancy between the NCHS data and the 
study results may be explained in a number of ways. 
Question 5 (How many different medications have 
you taken at home within the last year?) may have been 
misinterpreted by the patient, thus providing the 
investigator with incorrect information. 
The answers to question 5 may have been falsely 
lowered because of patient hesitancy to report the 
actual number of prescriptions taken at home. The 
patient may have been fearful that if he were taking 
a large number of medications, the investigator might 
suspect dependence or reliance on medication not 
really needed. 
The patients could have misinterpreted question 5 
to mean only prescription medication or over-the-counter 
items. They may have failed to include prescription 
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items when only over-the-counter medication was 
mentioned and vice-versa. 
Perhaps the recent trend toward improving health 
care for the elderly is reflected in lower medication 
usage. The public may be becoming better educated 
with respect to medication, leading to discrimina-
tion in drug usage. The lower prescription usage 
in the study population may reflect a healthier 
population in the Salt Lake City area. It would 
be very difficult to find evidence to support or 
contradict these explanations. 
The number of patients in the study may not have 
been large enough to accurately reflect prescription 
usage for the age groups studied. The study patients 
may not have been representative of the general 
population. These two explanations could help 
account for the discrepancy. 
All of the reasons outlined above could have 
played a role in the data obtained for question 5. 
Patient hesitancy to report the number of medica-
tions taken during the year, sample size and 
representation and patient misinterpretation of the 
question are the most likely explanations. 
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3. Questions 6 and 10 
Question, 6 (How many medications have you been 
given to take home with you?) and question 10 (Can 
you give me a list of all the medications that you 
will be taking at home after you are discharged 
from the hospital?) were analyzed by product-moment 
correlational analysis (see Results) to determine 
the extent of correspondence based on the patient's 
response to these questions. When the answers 
were compared, discrepancies were noted. 
Ten patients in the study did not respond to 
question 10 despite answering question 6. In every 
case, the patient did not know how to answer the 
question. Perhaps the question was phrased in 
such a way as to be confusing to the patient, leading 
to the patient attempting no response. Accurate and 
complete response to Question 10 requires that the 
patient have a good memory for the drug names and 
be able to pronounce the names correctly. If the 
patient was embarrassed because he could not pro-
nounce the names of the drugs, he may have withheld 
the answers. 
Health professionals may not tell the patient 
the actual name of the drug prescribed when counseling 
the patient about his medication. If this occurred 
with the study patients they would not be able to 
relate the name of the medication upon questioning. 
Finally the patients may have felt intimidated 
by the investigator. This could have led to the 
patients inability to accurately or consistently 
answer questions 6 and 10. 
4. Question 8 
Each patient in the study was asked to name the 
physician responsible for his care in the hospital. 
Forty-six patients responded. The information 
obtained did not significantly affect the study 
results nor did it add additional insight into the 
problem studied. 
Patients had some difficulty in answering this 
question. The question may have been poorly worded 
and some patients were confused as to the correct 
way to answer it. Some patients gave the attending 
physician names and others, housestaff physician 
names. 
5. Questions 9 and 11 
Some interesting data were uncovered when we 
compared the answers to the questions involving who 
counseled the patient and how adequate was the 
counseling the patient received. Twenty-one of 
fifty patients (42%) either indicated that they 
had no medication counseling of any kind or 
expressed conflicting answers regarding the health 
professional who counseled them about their 
discharge medications {see Results) . 
The patients may have been confused with the 
term "counseling" and because they may not have known 
what it meant, responded with "no one." Perhaps 
several patients did not receive counseling from 
anyone. This would indicate neglect on the part of 
health professionals in a very important aspect of 
health care. Physicians and/or nurses may neglect 
counseling the patients about their discharge 
medication because they know that pharmacists con-
sistently counsel patients at the time of discharge. 
These results should encourage individuals to design 
follow-up studies to critically examine the reasons 
discharge counseling is lacking. 
Eleven patients had conflicting answers concerning 
the health professional who counseled them. The 
patients may have been confused as to who counseled 
them. A pharmacist may have been perceived as a 
physician or vice versa. The health professional 
may not have correctly introduced himself to the 
patient and the patient may have incorrectly perceived 
the person as a physician. None of the patients were 
found to be significantly obtunded or drowsy which 
could have affected their identification of a 
health professional. However, several reasons are 
possible for the discrepancies noted. Patients 
may perceive anyone in a white coat as being a 
"doctor," especially if the person is male. Many 
patients come into a hospital setting with its 
familiar surroundings. There, the patient meets 
a variety of personnel unfamiliar to him. Allied 
health professionals may be perceived as physicians 
in such a setting. 
Physicians, pharmacists and nurses were all 
noted to have counseled the patient to the same 
extent. The adequacy ratings were very close to 
one another. Ten patients stated that no one had 
counseled them, yet they indicated a range of 
counseling adequacy from one to five (see Results). 
These data are obviously inconsistent and could 
not be used in the analysis of the final results 
of the study. 
6. Question 10 
The responses of the "counsel" and "no-counsel" 
groups to question 10 (see Appendix C) were analyzed 
and compared. The data are presented in Table 7. 
No statistically significant difference was noted 
between the two groups following Chi Square Analysis 
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(p>0.10). Each of the twelve sub-questions of this 
question was analyzed in this manner. 
7. Miscellaneous 
A number of patients did not respond to either 
question 4, 5, 6, or 7 of the questionnaire as 
mentioned in the results section. Patients not 
responding indicated that they simply did not 
know the answer. 
B. Drugs Assessed During the Study 
A small pilot study was conducted to determine the 
most common discharge medications prescribed by physicians 
on the fourth floor of the University Hospital (see 
Appendix J) . In view of the results, it was decided 
not to focus on a single class of drugs during the actual 
study period in keeping with the time restraints for data 
collection. 
If a single class or related group of drugs had been 
assessed, a difference may have been found between the 
groups. However, it would be difficult to extrapolate 
such results to other drug classes not assessed. 
If all the patient's discharge medications were 
assessed instead of a single drug, a difference may 
have been shown. Now, the entire impact of medication 
counseling could be assessed. Relying on a single drug 
may be insufficient to determine whether or not the 
.fife,. 
addition of pharmacist counseling makes a difference 
in patient drug knowledge. 
C. Study Environment 
The patient's environment was different than that 
which would be encountered in many other hospitals. 
The study was conducted at a large university 
teaching hospital. Patient care services in such a 
setting may be of a higher quality than that which 
may be found in a small private community hospital. 
Discharge patient counseling may be one area where this 
difference is evident. Perhaps in a large university-
affiliated teaching hospital, pharmacists, physicians 
and nurses provide the same level of information to 
the patient. Therefore, it would be difficult to deter-
mine that additional pharmacist counseling improved the 
drug knowledge gained by the patient. 
The environment in which the interview process took 
place may have played a role in the results obtained. 
Each interview was conducted in the patient's room where 
privacy was usually lacking. Perhaps this lack of pri-
vacy affected the way the patient's responded to the 
investigator's questions. The patients may have been 
embarrassed to accurately respond to questions for fear 
of being overheard by the other patients or by other 
staff members. 
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D. Pharmacist Responsibilities 
The decentralized pharmacists at University Hospital 
have a number of responsibilities on the patient wards. 
These responsibilities have been delineated (see Appendix 
A) . It can be seen that their time is spent in many ac-
tivities, only one of which is patient counseling. 
Since the responsibilities are many, the time spent 
counseling the patients may be minimal and only minimal 
information may be given to the patient. The level 
of counseling could conceivably be the same as provided 
by physicians and/or nurses to the patients. However, 
the time spent by pharmacists counseling was not 
controlled in the study. 
E• Decentralized Pharmacy Services at University Hospital 
The decentralized system may not be allowing sufficient 
time for the pharmacist to become involved in counseling 
to the extent that might show a difference in the data. 
23 
A recent unpublished study by Hibbard et al was 
completed by the Department of Pharmacy Services at 
University Hospital. The purpose of the study was to 
determine if a decentralized pharmacy distribution system 
would reduce the delivery time of a drug to the nursing 
unit as compared with a centralized system. 
The decentralized distribution system took significantly 
less time to deliver drugs to the nursing unit than the 
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centralized system. The authors stated that the decen-
tralized drug distribution system provided many benefits. 
One benefit noted was the opportunity the system gave 
to the pharmacists to become involved in clinical activi-
ties such as patient education and counseling. In 
view of the study results, these clinical activities 
may be lacking. 
F. Pharmacist Counseling Competency 
If the pharmacists have an adequate amount of time 
to counsel patients, the difficulty may arise in their 
ability to effectively counsel patients. This may be 
due to insufficient training in counseling skills, 
an area not stressed in pharmacy education. 
The level of the pharmacists' drug knowledge may 
be inadequate. The information provided to the patients 
during the discharge interview may be incomplete. 
Despite an educational program on counseling 
techniques in June 1978, a second program is 
recommended for the pharmacists. The results should then 
be compared to the original study. If a significant 
difference is found, pharmacist counseling habits 
might be implicated as a reason for the results found 
in the original study. 
One could not extrapolate this information to 
pharmacists in general. A counseling problem may 
be unique to the pharmacists who participated in 
the study. 
47 
G. Patient Experience with Prior Counseling 
No control for the patients' prior experience in 
dealing with a variety of health professionals and 
medication counseling was included in the study design. 
It could be said that the study was assessing patient 
knowledge already gained from past encounters with 
counseling. However, the likelihood of this is 
reduced because the drugs assessed in the study had not 
been taken previously by the patients. 
H. Influence of Daily Ward Rounds 
The medication knowledge gained by the patient 
during the daily ward rounds by the physicians and 
other health professionals is unknown. It could be 
one factor to explain the results obtained. Control-
ling for this factor is difficult and was not attempted. 
I. Investigator Bias 
Investigator bias may have affected the 
study results. The investigator developed the patient 
assessment questionnaire form and the assessment criteria 
and also assessed the patients' knowledge. The c ri in ex* i. 0 
were developed in an attempt to eliminate the investigator's 
bias in rating patient responses to the assessment 
questions. The reliability of the entire assessment 
questionnaire was not tested. However, the results of 
the independent rating of question 10 indicate that the 
investigator did not rate patient responses different 
from the rater. Still it is true that the investigator 
trained the rater, and his bias could have been imparted 
to the rater unintentionally during the training process. 
J. Study Contamination 
The mechanics of the study could have had an effect 
on the data obtained and the final results. A copy of 
the consent form was placed in the patients chart after 
each interview. It is conceivable that the pharmacists, 
physicians and nurses encountered in the study could 
have read the consent form in the patients chart. This 
information may have alerted them to the nature of the 
study with subsequent enhancement of medication coun-
seling during the period of the study. Any assessment 
of pa. ti.Gn.fc knowledge during this time period would yield 
results indicating no difference in the two study groups. 
One nurse indicated that she had read the consent form 
and knew the basic intent of the program,* yet, she could 
not relate specific information about the study. 
There were several occasions where the pharmacist 
told the investigator to assign a particular patient 
to a different number than what the investigator had 
originally assigned. When this was done, the inves-
tigator assumed that the pharmacist was going to counsel 
the patient. Whether this occurred or not was not deter-
mined . It is doubtful if this affected the investigator's 
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approach to the patient or the consistency with which 
he asked the questions. 
K. Sample Size 
The number of patients who participated in the study 
may not have been adequate. If a true difference in 
the data existed, it may not have been detected with 
the sample size used in the study. 
L. Assessment Criteria Bias 
Another explanation is the ct s s 6 s s me in t c 2r x teir i. si # used 
in aiding the investigator to rate the patient responses 
for question 10. Sub-question 8, 9, 10 and 11 had criteria 
which stated that if a patient lacked medication knowledge 
secondary to counselor failure to provide the needed 
information to appropriately answer the question, the 
investigator-will record the answer as correct. Thus 
no knowledge would be rated as correct; in reality the 
patient lacked knowledge. A true difference between the 
groups may have been hidden. 
M. Miscellaneous 
The knowledge gained by the patient appeared 
adequate despite the health professional who may have 
counseled the patient. However, what effect the infor-
mation gained will have on patient compliance is not 
known and should be considered in future studies of 
this kind. Ideally, a follow-up study should be designed 
to look at this aspect. 
50 
VII. CONCLUSION 
A study was undertaken to determine if pharmacist 
counseling of hospitalized patients significantly improves 
the patient's knowledge of a drug prescribed by a physician 
upon discharge from the hospital. Specific study objectives 
were identified, followed by the development of an assess-
ment questionnaire to measure patient knowledge. Data 
were obtained on 50 patients and analyzed. The analysis of 
the data suggests that pharmacist counseling, in addition 
to physician and/or nurse counseling, made no difference 
in the over-all medication knowledge of the patient when 
compared to only physician and/or nurse counseling. 
Several reasons have been offered to explain the results. 
All of the explanations are viable. However, two reasons 
appear likely, (1) either the study was designed such that 
no difference could be detected between the two study 
groups, or (2) the pharmacists lacked adequate counseling 
skills. 
Further modification of the assessment questionnaire 
and assessment criteria used to evaluate the patient 
responses may be necessary to provide more accurate measures 
of medication knowledge. If the study results are accurate, 
the pharmacist's role in discharge counseling should be 
reexamined. Pharmacists may need additional training in 
counseling techniques. 
The author will conduct the same study in a private, 
community hospital to assess what effect environment has on 
patient knowledge of discharge medications. 
The pharmacists at University Hospital will undergo 
an in-service educational program. The program will focus 
on proper counseling techniques and drug information. 
Following the program, the study will again be c onclucted 
on the fourth floor of University Hospital. A comparison 
of the results from both studies will be made. These efforts 
may determine whether or not pharmacist counseling skills 
and drug knowledge base were responsible for the study results. 
I encourage other investigators to conduct similar 
research in an effort to answer some of the questions raised 
by these studies. It is hoped that this study provided 
a framework with which to develop similar programs so 
that some of the questions raised might be answered. If 
pharmacy as a profession is to remain viable, the CX J3C I* "t«X s o 




Decentralized Pharmacist Job Responsibilities 
Job Responsibilities for the Pharmacists include: 
1. Provide patient education 
2. Obtain medication histories on selected patients 
3. Provide discharge medications and counseling to all patients 
4. Provide drug information to physicians, nurses and other 
health professionals 
5. Provide ongoing liaison between hospital staff members 
and the Drug Information Center 
6. Monitor patients drug therapy 
7. Provide referral for IV orders to the IV Admixture Center 
8. Participate in in-service presentations to nurses and 
physicians 
9. Provide pharmacy services to associated patient care 
areas, i.e., operating room, anesthesiology, recovery 
room and ambulatory surgery 
10. Verifying all transcriptions on the medication adminis-
tration record-patient profile 
11. Assuring that all orders were filled with an adequate 
supply for a 24 hour period 
12. Checking the unit dose carts after they were filled by 
technicians 
13. Clarifying unclear drug orders with the physicians or 
nurses as appropriate 
14. Responding to "stat" requests for pharmaceutical services 
15. Rectifying doses that were not administered as scheduled 
16. Rectifying missing doses 
17. Verifying controlled substances administration records 
18. Supervising pharmacy technicians in weekly floor inspections 
Appendix B 
Reasons for Study Subject Ineligibility 
Refusal to participate 
Hearing and/or speech impaired. These disabilities would 
obviously cause difficulty for both the patient and 
the investigator. The pharmacist-counselor would have 
had difficulty relating information to this group of 
patients and the patients would have had difficulty 
in understanding information transmission by the coun-
selor. Also, there may have been difficulty for the 
patient to relate prescription drug knowledge to the 
investigator. These reasons may have imparted bias 
in the study which may have affected the eventual 
outcome of the study. 
If the prescribed medication had been taken/given within 
the last year. This was implemented in order to control 
for the patient's prior experience with the medication 
which was being assessed. If the patient had taken 
the drug which was assessed within the last year, 
this could have affected the responses given to the 
investigator and biased the results as well. The 
impact of pharmacist counseling could not be determined 
under these circumstances. 
Non-english speaking patients. A language barrier 
would have made it difficult to effectively communicate 
with the patient, information relating to his medica-
tion. Difficulty would have been encountered trying 
to elicit answers from the p (En. L. ML. c!*. n t^  9 
Patients discharged to a nursing home who will not be 
taking their own medication. The intent of the study 
was to assess only those patients who would be self-
administering and be responsible for their own medications. 
In this situation, patient knowledge concerning their 
medication and the proper method of administration is 
important. Patients admitted to a nursing home usually 
are not responsible for taking their own medication. 
Patients discharged with more than 6 new prescriptions. 
Only new prescriptions were assessed. The drugs 
assessed in the study were only drugs which the patient 
had not taken before. However, if the drug had been 
taken more than a year from the time of the assessment 
the drug would be assessed. 
It was decided that if a patient was discharged with 
more than 6 new prescriptions, the patient may have 
been confused when one of those drugs was randomly 
chosen and assessed and this may have an effect on the 
patients responses. 
Patients younger than 18 years and older than 75 
years of age. A young population of patients and a 
very old population of patients were excluded due to the 
possibility that this group of patients might be 
unable to understand the information provided them by 
the counselors. It would have also been difficult to 
assess medication knowledge in such an age group. 
Appendix C 




PATIENT MEDICATION KNOWLEDGE QUESTIONNAIRE 
1. What is your age? 
2. Male Female 
3. How many years of schooling have you had? 
4. How many medications have you been taking on a regular 
basis at home? 
5. How many different medications have you taken at home 
within the last year? • 
6. How many medications have you been given to take home 
with you? 
7. How many medications have you been given to take home 
with you which you have never taken before? 
8. What is the name of the physician who was taking care of 
you in the hospital? 
9. How adequate was the counseling you received regarding 










Rather good Very thorough 
counseling and adequate 
2 4 5 
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10. Assessment of patient's knowledge of medication. 
Can you give me a list of all the medications that you 
will be taking at home after you are discharged from 
the hospital? 
Let's talk about just one of your medications 
Sig: 
a. For what condition are you taking this medication? 
Correct 
Incorrect 
b. What is the strength of this medication? 
C» C5 3C IT t 
Incorrect 
c. Will you be taking this medication by mouth? yes no 
Correct 
Incorrect 
d. How many times per day should you take this medication? 
Correct 
Incorrect 





f. How much of the medication do you take in a single dose? 
Correct 
Incorrect 
g. How many days will this prescription last? 
Correct 
Incorrect 
h. Is there any food you should avoid while taking this 
medication? yes no 
Correct 
Incorrect 
i. Are there any drugs you should avoid while taking this 
medication? yes no 
Oo ITlT60 *fc 
Incorrect 
j. Are there any activities you should avoid while taking 
this medication? yes no 
Correct 
Incorrect 
k. Are you aware of any side effects which may occur with 




1. Are there any other special directions or precautions 
that you were told concerning this medication? yes no 
If yes, what are they? 
Correct 
Incorrect 







Rationale for Medication Knowledge Questionnaire 
Question Analysis 
1. What is your age? 
The question was included to ascertain whether or not 
patient age was a factor in patient responses to the 
questions assessing medication. 
2. Male Female 
The question was included to ascertain the relationship of 
sex to how the patients responded to the questions 
assessing medication knowledge. 
3. How many years of schooling have you had? 
The question was included to assess the relationship 
between years of formal schooling and how patients 
responded to the questions assessing medication knowledge. 
4. How many medications have you been taking on a regular 
basis at home? 
The question was included to obtain information as to 
how many medications the patients were taking at home. 
This information should relate to the patient's exper-
ience with taking medication. Both over-the-counter 
and prescription medications or both are acceptable answers 
to this question. 
5. How many different medications have you taken at home 
within the last year? 
The question was included to assess the patient's exper-
ience with either over-the-counter or prescription 
medication. The patient could respond with either a 
numerical answer or with the names of the medication. 
A numerical answer will only be considered appropriate. 
The question requires that the patient rely on his/her 
ability to remember drug use over a one year time 
period. 
6. How many medications have you been given to take home 
with you? 
The question was included to determine the number of 
discharge prescriptions the patient will be taking home 
with him/her. 
7. How many medications have you been given to take home with 
you which you have llSV€5ir tcilcS n before? 
The question was to determine the number of discharge 
medications the patient had ever taken before. 
8 » What is the name of the physician who was taking care 
of you in the hospital? 
The question was to determine how well the patient 
knows the physician(s) responsible for their care in 
the hospital. The question requires the patient to rely 
on his memory in order to answer the question. 
9. How adequate was the counseling you received regarding 
your discharge medications? 
Some counseling 
No but very Barely Rather good Very thorough 
counseling inadequate adequate counseling and adequate 
1 2 3 4 5 
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The question was asked to determine the patient's 
perceived adequacy of the information provided him 
concerning his discharge medication. The question 
comprised five ratings which include a broad range of 
responses to accurately reflect the level of counseling. 
This question was asked following question 7 (i.e., who 
counseled you regarding your discharge medication?). 
Questions 9 and 11, were asked last to prevent the 
investigator from knowing who counseled the patient 
prior to the drug knowledge assessment questions. 
Assessment of patient's knowledge of medication. 
This question is composed of three parts. 
Part One - "Can you give me a list of all the medi-
cations that you will be taking at home after you 
are discharged from the hospital?" 
This question is similar to question 6. It requires 
that the patient tell the investigator the names of 
the prescription medication that he will be taking 
at home. This question was included to assess the 
reliability of the patient in answering a similar 
question. The question will determine if the patients 
can name the medication they have to take home with 
them. 
Part Two - "Let's talk about just one of your 
medications." 
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This statement will alert the patient that the 
investigator will be discussing only one of the 
patient's discharge medications. 
Part Three - Twelve sub-questions are asked to 
determine the patient's understanding of the drug 
being assessed plus basic knowledge of the drug. 
Questions 3 and 8 through 12 are questions which 
require that the patient answer first with either 
a yes and no. Yes/No columns have been provided 
for these questions. Each question has associated 
with it a correct/incorrect column. 
Sub-questions 7 through 12 were developed with respect 
to questions which would be required to assess that 
knowledge which is important for the patient to 
know. Questions concerned with indications for use, 
dose, route of administration, times of adminis-
tration, side effects and others were included. 
11. Who counseled you regarding your discharge medications? 
physician nurse 
pharmacist other, specify: 
none 
The question determined what health professional counseled 
the patient. 
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For what condition are you taking this medication? 
Correct 
a. The patient will be allowed to rely on the following 




Written information provided by the counselor 
(Investigator prodding will not be allowed) 
b. Precise medical terminology does not have to be used 
by the patient in answering the question. The patient 
will be allowed to describe his/her illness in what-
ever way the patient feels comfortable, provided it 
accurately depicts the disease state in question. 
c. The disease being treated must be found in the 
manufacturer's package insert or an investigational 
use for the drug. 
d. If the patient has several diseases which are being 
treated with the drug in question, the patient must 
have knowledge of at least one of the disease states. 
e. If the patient has several diseases which are being 
treated with the drug in question and gives the 
investigator the names or a description of the diseases, 
one disease state must be correct. 
f. If the patient has no knowledge of the disease for 
which the medication was prescribed, but later in 
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the interview remembers the disease name or can 
explain the disease correctly. 
Incorrect 
a. No knowledge of the disease for which the medication 
was prescribed. 
b. Wrong response given to the investigator. 
c. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
d. Patient indicates that he/she knows the reason for 
taking the medication, but cannot explain the reason 
to the investigator. 
e. The patient may have taken the medication in the past 
for a particular reason and has now been given the same 
medication for a different reason. If the patient 
responds with an answer which relates to the previous 
condition but not the currect condition, the response 
is incorrect. 
2. What is the strength of this medication? 
Correct 
See a. question 1. 
Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only 
after conferring with either a family member 
70 
and/or friend at the time of the interview, 
c. Wrong response given to the investigator. 
3. Will you be taking this medication by mouth? 
Correct 
See a. question 1. 
Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
frient at the time of the interview. 
c. Wrong response given to the investigator. 
4. How many times per day should you take this medication? 
Correct 
a. See a. question 1. 
b. If the medication is given either once daily or 
every other day, only once daily or every other day 
will be accepted by the investigator as a correct 
response. 
c. If the medication is given two, three or four times 
a day, the acceptable answers are: 
1. Two times daily - one, two, or three times 
daily 
2. Three times daily - two, three, or four 
times daily 
3. Four times daily - three, four, or five times 
daily 
d. Prn (i.e., "if needed") Medications - the patient must 
state to the investigator that he/she is to take 
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the medication only if needed as directed by the 
physician. 
Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Answers other than what is listed under Correct c. 
above. 
d. Prn Medications - if a limit was placed on the number 
of doses of medication to be taken, and if this 
information is not told to the investigator. If 
the patient tells the investigator a number of doses 
which exceeds that indicated on the prescription. 
At what times during the day should you take the medication? 
Correct 
a. See a. question 1., provided the counselor gave the 
patient specific times. 
b. If the patient cannot relate specific times, but has 
general knowledge as to when to take the medication 
(i.e., with meals and at bedtime). 
c. If the patient was given specific times for drug ad-
ministration by the counselor or if the times were 
indicated on the actual prescription but cannot relate 
the specific times but is within one hour (high or low) 
of the actual time. 
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Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only-
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Answer other than what is listed under Correct c. above 
6. How much of the medication do you take in a single dose? 
Correct 
a. See a. question 1. 
b. Only the exact amount will be correct. 
c. If the patient was instructed by the counselor to 
take either one or two tablets, capsules, teaspoonsful, 
tablespoonsful, inhalations, suppositories, etc., 
based on the patient's symptoms this must be related 
to the investigator. 
Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Wrong response given to the investigator. 
7. How many days will this prescription last? 
Correct 
a. See a. question 1., provided the answer is exact. 
b. The question could be answered in one of two ways: 
1. The length of time the initial filling of the 
prescription will last if taken as directed by 
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the patient (i.e., 50 capsules, take one capsule 
daily, the prescription should last 50 days). 
2. The life of the prescription (i.e., the number of 
refills which could be obtained). 
c. If the patient responds to 1. of part b. above, the 
patient will be allowed to figure the number of days 
the prescription will last. The answer must be within 
2 days (high or low) of the actual time. 
d. If eye drops are being evaluated, the difficulty in 
a patient calculating the number of days his/her 
dropper bottle will last, mandates against any answer 
being scored. 
e. If the patient relates both the life of the prescription 
and the number of days it will last, only one response 
must be correct. 
Incorrect 
a. No knowledge given to the investigator, 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Incorrect answer as outlined on Correct c. above. 
Is there any food you should avoid while taking this 
medication? 
0 OX3TS C t 
a. See a. question 1. 
b. If more than one food was mentioned by the counselor 
but the patient can only remember one or a few of the 
foods. 
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c. The food(s) mentioned by the patient should be ones 
having a documented interaction with the drug in 
question and which could be verified by consulting 
the following; (clinical significance of the inter-
action will not be assessed) 
1. Hansten's Drug Interactions, 3rd Edition 
2. American Pharmaceutical Association's Evaluations 
of Drug Interactions, 2nd Edition 
d. Lack of knowledge of a drug-food interaction, 
due to counselor failure to provide such information, 
as told to the investigator by the patient, will be 
recorded as a correct answer. 
e. If the patient mentions a food not mentioned by the 
counselor but which is correct as outlined under 
IT 2T 6 CJ t. c. above. 
Incorrect 
a. No knowledge given to the investigator. 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Wrong response given to the investigator. 
Are there any drugs you should avoid while taking this 
medication? 
Correct & Incorrect 
Same as question 8., substitute drug(s) for foods(s). 
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Are there any activities you should avoid while taking 
this medication? 
Correct 
a. See a. question 1. 
b. If more than one activity was mentioned by the 
counselor but the patient can only relate one or 
a few activities. 
c. Lack of knowledge of an activity to avoid, due to 
counselor failure to provide such information, as 
told to the investigator by the patient, will be 
recorded as a correct answer. 
Incorrect 
a. If the patient mentions an activity not specifically 
mentioned by the counselor, then the investigator will 
record an incorrect answer. 
b. No knowledge given to the investigator. 
c. Correct response given to the investigator but 
only after conferring with either a family member and/ 
or friend at the time of the interview. 
d. Wrong response given to the investigator. 
Are you aware of any side effects which may occur with 
this medication? 
Correct 
a. See a. question 1. 
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b. Side effects mentioned by the patient should be ones 
which can be documented in standard accepted compendia 
dealing with drug side effects: 
1. American Hospital Formulary Service 
2. Manufacturer's package insert 
3. Myeler's Side Effects of Drugs 1978, 1979 Supplements 
c. If the patient answers "yes" and can name several 
side effects which are correct (see b. above) . 
d. No knowledge of side-effects, due to counselor failure 
to provide such information to the patient, will be 
recorded as a correct answer by the investigator if 
the patient responds "no" to the question. 
e. If the patient relates specific side-effects to the 
investigator, the patient must obtain the following 
correct answers: 
# Side effects 
(Listed by Patient) Correct Answers Needed 
1 1 (100%) 
2 1 (50%) 
3 2 (67%) 
4 3 (75%) 
5 4 (80%) 
Incorrect 
a. No knowledge given to the investigator. 
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b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
c. Wrong response given to the investigator. 
d. If the patient responds "yes", but cannot name any 
side effects. 
Are there any other special directions or precautions 
that you were told concerning this medication? 
G O JC IT 6 C *t 
a. See a. question 1. 
b. If the patient responds "no", it will be recorded as 
a correct answer due to the difficulty in assessing 
what was told the patient by the counselor. 
Incorrect 
a. If the patient answers "yes", but cannot relate any 
specific direction or precaution. 
b. Correct response given to the investigator but only 
after conferring with either a family member and/or 
friend at the time of the interview. 
Appendix F 
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CONSENT AND AGREEMENT TO PARTICIPATE IN THE RESEARCH PROJECT... 
"Assessment of Pharmacist Medication Counseling 
of Hospitalized Patients" 
Date; , 
The clinical research project in which I am volunteering to 
participate as an experimental subject has been fully 
explained to me as to the procedure, benefits and risks 
involved as are outlined below. 
1. Prior to discharge from the hospital, either a pharmacist 
or a non-pharmacist health professional or both will 
discuss with me the proper way to take the medication(s) 
prescribed for me. 
2. A short time later, I will be interviewed in order to 
find out how well I understand my medications. 
3. By undergoing this interview, there will not be any 
additional cost to me over my normal hospitalization 
expenses, nor will there be any financial reward for 
my participation. 
4. The quality of health care I receive at this hospital 
and during future hospitalizations or clinic visits, if 
ever necessary, will remain the same if I do not choose 
to participate in the study. 
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5. This study involves no harmful procedures, therefore, 
the potential physical risks to me are minimal. 
6. If it is determined after the interview that I have 
misinterpreted or misunderstood the drug or prescription 
instructions, this will be corrected so that I may 
achieve the maximum benefit from the intended therapy. 
I acknowledge that I have had a fair opportunity to ask 
questions about the above items. I understand that I am 
free to withdraw my consent and to discontinue participation 
in the project at any time without prejudice. I agree that 
data from these experiments may be used for medical and 
scientific purposes, including publication, with the 
understanding that my identity will not be revealed unless 
I expressly consent thereto. 
Medical treatment or compensation for physical injury: In the 
event you sustain physical injury resulting from the research 
project in which you are participating, the University of Utah 
will provide you, without charge, emergency and temporary 
medical treatment not otherwise covered by insurance. Further-
more, if your injuries are caused by negligent acts or 
omissions of University employees acting in the course and 
scope of their employment, the University may be liable, 
subject to limitations prescribed by law, for additional medical 
costs and other damages you sustain. If you believe that you 
have suffered a physical injury as a result of participation 
in this research program, please contact the Office of Research 
Administration, Phone No. 581-6903. 
Patient: Signature: 
Responsible Investigator's Signature: 
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Our hospital 1s considering Implementation of a new program which 
will deal with educating patients on the proper use of medications. We 
would appreciate yourhelp in this effort by answering a few short questions. 
Questions: 
1, How many medications have you been taking on a regular 
basis at home? 
2. How many different medications have you taken at home 
within the last year? 
3. Are you allergic to any medications? ^es ( ) no ( ) 
If yes, what medications (1 ist al 1) 
4. How many vitamin pills do you take per day? 
5. In which of these places do you keep prescription medications? 
Medicine cabinet 1n bathroom Handbag 
Drawer in bedroom bureau Wallet 
Kitchen cupboard Automobile 
Other, please specify 
6. In which of these places do you keep non-prescription medications? 
Medicine cabinet in bathroom Handbag 
Drawer in bedroom bureau Wallet 
Kitchen cupboard ^Automobile 
Other, please specify 
We thank you for your help and would ask that you include your name 




boL^F C R O S S b o s p f t a i 
1045 east first south . . . salt lake city, utah 84102 . . . telephone 801 . 350 . 4111 
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Drug Classes Assessed During the Study 
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Drug Classes Encountered During the Study 
No. of Drugs Percentage 
1. Analgesics 8 16 
2. Antibiotics 5 10 
3. Diuretics 4 8 
4. Nitrates 3 6 
5. Topicals 3 6 
6. Estrogens 2 4 
7. Anti-Gout 2 4 
8. Anticoagulants 2 4 
9. Vitamins < 2 4 
10. Steroids 2 4 
11. Iron Preparations 2 4 
12. Minor Tranquilzers 2 4 
13. Insulin 1 2 
14. Anti-Emetics 1 2 
15. Anti-Neoplasties 1 2 
16. Ovulation Stimulants 1 2 
17. Barbiturates 1 2 
18. Sympathominetics 1 2 
19. Digitalis Preparations 1 2 
20. Potassium Supplements 1 2 
21. Thyroid Preparations 1 2 
22. Cough and Expectorant 
Preparations 1 2 
23. Theophylline 1 2 
24 . Gl Drugs 1 2 
TOTAL 50 100 
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Specific Drugs Assessed During the Study 
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1. Aminophylline 26. R Percocet 
2 • Dihydromorphone 27. Tylenol No. 3 R 
3. Cimetidine 28. Conjugated Estrogens 
4 . Prochlorperazine 29. Ferrous Gluconate 
5 . Conjugated Estrogens 30. Furosemide 
6. Allopurinol 31* TJ Percocet 
7. Warfarin 32. Nitroglycerin S. L. 
8. Tylenol No. 3 R 33. Calcitrol 
9. Nitroglycerin Ointment 34 . Insulin 
10. Furosemide 35. Nystatin Vag. Suppos. 
11. Vitamin D 36 . Hydrochlorothiazide 
12. Bleomycin 37. Nitrofurantoin 
X 3 • Erythromycin 38. Warfarin 
14 . Clomiphene 39. o Perocet 
15, Phenobarbital 40. Insulin 
16. Estar Ointment 41. Digoxin 
17. Prednisone 42. K-L0RR 
18 . Ampicillin 43. Levothyroxine 
19. Metaproterenol Inhaler 44 . Prednisone 
20. Ferrous Sulfate 45 . Nitroglycerin Ointment 
21. Allopurinol 46. Hydrocortisone Cream 
22. Tylenol No. 3 R 47. Elixir of Terpin Hydrate 
with Codeine 
23 . Flurazepam 
R 48 . Furosemide 24 . Percocet rs 
49 . JV 
Hibiclens Soap 2 o * Dicloxacillin 
50 . Flurazepam 
Appendix I 
Annual Prescription Usage for Men and Women Encountered 
During the Study 
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Question 5 - How many different medications have you taken 
at home within the last year? 
Females - 65 years and older: 3.7 prescriptions (based on 
5 patients). 
65 years: 2.8 prescriptions (based on 21 patients) 
Males 65 years and older: 3.4 prescriptions (based on 
5 patients). 
65 years: 2.3 prescriptions (based on 14 patients) 
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Classes of Discharge Medication Prescribed by Physicians: 
Fourth Floor Pilot Study (One week collection time) 
Drug Class Number Percentage of Total 
Analgesics 10 17 
Cardiac Agents 8 13 
Antihypertensives 7 12 
Vitamins 5 8 
Corticosteroids 4 7 
Stool Softeners 4 7 
Minor Tranquilizers 3 5 
Antineoplastics 3 5 
Ophthalmics 3 5 
Potassium Supplements 2 3 
Antihistamines 2 3 
Antibiotics 2 3 
Gastrointestinal Agents 2 3 
Phenothiazines 2 3 
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States Where Licensed 
The University of Utah 
1115 Medical Plaza 
Salt Lake City, Utah 84112 
The University of Utah 
College of Pharmacy 
Department of Pharmacy Practice 
Salt Lake City, Utah 84112 
(801) 581-5941 




Connecticut - since December 9, 1975 
Utah - since July 25, 1978 
Career Goals 
My career objectives are the development, implementation and maintenance 
of progressive programs in pharmacy education and practice in the 
areas of Internal Medicine and/or Ambulatory Care (Family Practice). 
These objectives will be fulfilled utilizing the expertise gained 
in academic course work and experience situations encountered to date. 
Educational Background 
May 1975 Bachelor of Science in Pharmacy 
degree was received from the 
University of Connecticut 
School of Pharmacy 
June 1980 Doctor of Pharmacy degree is 
presently pursued and will be 
completed at the University of Utah 
College of Pharmacy 
Major Advisor: George E. Dukes, Pharm.D. 
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Educational Experience 
ASHP Accredited Residency in Hospital Pharmacy, Yale-Hew Haven Hospital, 
New Haven, Connecticut, June 30, 1975 to June 25, 1976. 
Residency experience: Departmental Administration, Drug Distribution 
and Control, Ambulatory Patient Services, Drug Information Services, 
Participation in Teaching Activities, Quality Control, Clinical 
Pharmacy Practice, Purchasing and Inventory Control, and Sterile 
and Nonsterile Product Formulation. 
Doctor of Pharmacy Program 
Core Clerkships 
6 wks - Ambulatory Care (Family Practice Center, Outpatient Pediatric 
Clinic, Maternity ./Infant Care Clinic) 
10 wks - Drug Information 
6 wks - Neuropsychiatry 
6 wks - Surgery 
6 wks - Pediatrics 
11 wks - Internal Medicine 
Elective Clerkships 
11 wks - Internal Medicine/Family Practice 
6 wks - Pediatrics 
3 wks - Gastroenterology 
3 wks - Outpatient Neuropsychiatry 
7 wks - Ambulatory Care (Family Practice Center) 
6 wks - Nephrology 
6 wks - Obstetrics/Gynecology and Maternity/Infant Care Clinic 
Special Elective Clerkship 
2 wks - Yellowstone Medical Services, Lake Hospital, Yellowstone 
National Park, Wyoming, Summer 1979. 
Professional Experience 
1973 Pharmacy Apprentice, Summer Employment 
WH Pickett Drug Co., Waterbury, Connecticut 
1974 NPC/SAPhA Pharmaceutical Industry Intern, 
Summer Employment, Ortho Pharmaceutical 
Corp., Raritan, New Jersey 
1975 June, Pharmacy Intern, Woodbury Drug Co., 
Woodbury, Connecticut 
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Professional Experience (cont'd) 
June 30, 1975 - June 25, 1976 
August 30, 1976 to June 2, 1978 
-
ASHP Accredited Residency in Hospital 
Pharmacy, Yale-New Haven Hospital 
New Haven, Connecticut 
Ambulatory Service Pharmacist, Yale-New 
Haven Hospital, New Haven, Connecticut 
Professional Societies and Positions Held 
American Pharmaceutical Association 
APhA - Academy of Pharmacy Practice - Clinical Section 
American Society of Hospital Pharmacists 
Connecticut Pharmaceutical Association (CPA) 
Connecticut Society of Hospital Pharmacists (CSHP) 
Associate Member - National Intravenous Therapy Association 
Life Member - University of Connecticut School of Pharmacy Alumni Association 
New England Council of Hospital Pharmacists (NECHP) 1975 - 1976 
American Association for the Advancement of Science 
Planning Committee - NECHP Fall & Spring Seminars, 1975 - 1976 
CSHP - Continuing Education Committee, 1977 and 1978 
CPA - Continuing Education Committee, 1977 (Inactive) 
CPA - Pharmacy Student Liaison Committee, 1977 and 1978 (Inactive) 
Member - Task Force on Pharmacist Orientation, Yale-New Haven Hospital, 1977 
Chairman - Continuing Education Committee - CSHP, March 1977 to July 1978 
Member - Mutual Respect Committee, Yale-New Haven Hospital, 1977 to July 1978 
Member - Sub-Committee (Mutual Respect Committee) - Mutual Respect Week 
Slogan Contest, Yale-New Haven Hospital, Fall 1977 
Member - Sub-Committee (Mutual Respect Committee) - Publication of 
bffiC History, Yale-New Haven Hospital, Spring 1978 
Co-Chairman - Nursing/Pharmacy Committee on Written Patient Information, 
Yale-New Haven Hospital, 1977 - 1978 
Student Member - Utah Society of Hospital Pharmacists, Utah Pharmaceutical Assoc 
Professional and Educational Activities 
Student Memberships 
Connecticut Society of Hospital Pharmacists 
Connecticut Pharmaceutical Association 
American Pharmaceutical Association 
American Society of Hospital Pharmacists 
Husky Trap and Skeet Club and Team (University of Connecticut) 
Interorganizational Council (School of Pharmacy) 
Drug Abuse Team (School of Pharmacy) 
Hilltop Council (Dormitory Organization) 
-4-
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Professional and Educational Activities (cont'd) 
Student Committees and Offices Held 
Secretary - Husky Trap and Skeet Club, 1972-1973 
Secretary - Fourth Year Class, School of Pharmacy 1973 - l<m 
Member - SAPhA National House of Delegates W 4 - 1975 
President - University of Connecticut Chapter of SAPhA, 1974 - 1975 
Co-Chairman ~ S T T ^ Screening Clinic, 1975 Co-Chairraan - Student Committee, Planning Open House for 1975 
Fiftieth Anniversary Celebration of School of Pharmacy 
Member - Student Committee, Co,missioned by President Glen Fereuson 
(University of Connecticut) for input in search committee recommen-
dations tor a vice-president for health affairs, 1975 
Contributing Author - Region I SAPhA Newsletter, 1974 - 1975 
Teaching Experience 
Instructor in Pharmacology - Respiratory Therapy Students - St. Raphael's 
Hospital, New Haven, Connecticut, 1975 - 1976 
Instructor in Pharmacology - RNs, LPNs, OR&RR Nurses and Respiratory 
Therapy Students, Yale-New Haven Hospital, 1975 - 1976 
Pharmacology Course Coordinator - Respiratory Therapy Students, Yale-
New Haven Hospital, 1976 
Lecturer - Pharmacy Technician Education Course, Yale-New Haven Hospital, 
1977 
Lecturer - Nursing In-Service (Chronic Hemodialysis Unit), Yale-New 
Haven Hospital, 1977 - 1978 
Instructor - 12th LPN Medication Course, Yale-New Haven Hospital, 1977-
1978 
Presentations 
Speaker - NECHP Spring Seminar - "Non-Parenteral Nutrition," June 8 
and 9, 1976, Framingham, Massachusettes 
Poster Session - "Utilization Review of Nutritionally Complete Liquid 
Diets," (with Arthur G. Lipman and C. Patrick Moran), presented at 
the 11th Annual ASHP Midyear Clinical Meeting, Anaheim, Calif., 
December 1976 
Guest Lecturer - Nursing In-Service Pharmacology Program, St. Mary's 
Hospital, Waterbury, Connecticut, May 12, 1977, Topic: "Non-
Parenteral Nutrition" 
Poster Session - "Utilization Review of Nutritionally Complete Liquid 
Diets," (with Arthur G. Lipman and C. Patrick Moran), presented at 
the 24th Annual Seminar - New England Council of Hospital Pharmacists, 
Newport, RI, June 2-4, 1977 
Speaker - Monthly Meeting - Connecticut Society of Hospital Pharmacists, 
Meriden-Wallingford Hospital - October 18, 1977, Topic - "Complete 
Oral Liquid Diets" 
Conference Workshop Leader - "Current Concepts and Practices in 
Respiratory Care for the Geriatric Patient Sponsored by the South 
Central Branch of the Connecticut Lung Association - November lb, //, 
Bently Gardens Nursing Home, Topic: "Role of Medications in 
Chronic Obstructive Lung Disease" 
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Professional and Educational Activities (cont'd) 
Presentations (cont'd) 
Poster Session - "A Study of Medication Teaching Aids" by Gregory 
Gousse, Charles D. Ponte and Henry Palmer. Presented at the 12th 
Annual ASHP Midyear Clinical Meeting, Atlanta, Georgia, December 1977 
Program Chairman and Moderator - 2nd Annual Seminar (Connecticut 
Society of Hospital Pharmacists) - "Ambulatory' Pharmacy Service 
Update," University of Connecticut Health Center, Farming ton, Conn., 
February 4, 1978 
Guest Speaker - Respiratory Club of Gay lord Hospital, Wallingford Conn. 
Co-sponsored by Connecticut Lung Association, South Central Branch, 
June 22, 197 8, Topic; Types and Uses of Respiratory Medication. 
Miscellaneous 
Speaker - Careers Day - Mansfield Middle School, 1975 
Pharm.D. Clerkship Presentations 
Neuropsychiatry - Nursing Staff Meeting - Topic; "Phenothiazines" 1979 
VA Hospital, Salt Lake City, Utah 
General Surgery - Surgical Intensive Care Unit - Nursing In-Service, 
Topic: "Treatment of Angina" 1979, University of Utah Medical 
Center Hospital 
Pediatrics - Nursing In-Service Pediatric Intensive Care Unit, 
Topic: "Review of Adenine Arabinoside in the Treatment of Herpes 
Encephalitis" 1979, University of Utah Medical Center Hospital 
Yellowstone Medical Services - Lake Hospital - Nursing In-Service, 
Topic: "General Principles of Toxicology" 1979, Yellowstone 
National Park, Wyoming Pediatrics - Housestaff Conference, Topic: "Enteral Alimentation 1979 
University of Utah Medical Center Hospital 
Internal Medicine/Family Practice - Family Practice Housestaff 
Presentations, Topics: "Treatment of Pain," "Lidocaine Pharmaco-
kinetics," 1979, Holy Cross Hospital 
Medical Students - Daily Mini-Therapeutic Conferences, Topics: 
"Antibiotic Use," "Review of Cathartics," "Treatment of Diarrhea, 
'Treatment of Portal systemic Encephalopathy," "Diuretic Therapy 
of CHF and Ascites," etc. „ r H r . .. u,, o f Pharmacist Staff Meeting, Topics: Review of Ca ^ r c , U e 
Diuretics in the Treatment of CHF," Holy Cross Hospital 
faqtroenterology - Medical Students - Topics: "Treatment of Portal 
" i r s t - i c Encephalopathy, " "Review of Carthertics," "Treatment of 
Peptic Ulcer Disease." r n i i r_ p University Teaching Fellow - Undergraduate Drug Information Course 
of Utah, College of P h a r m a c y , Sept. 2 - Dec 8, 197 
Teaching Fellow - Undergraduate Surgery CI rkship Unive 
Utah, College of Pharmacy, Jan. 29 - Marcn University 
Disease," Nov. 16, 1979 
- 6 -
Natlon.il and Regional Professional Meeting Attendance 
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SAPhA National Convention, Chicago, Illinois, August 1974, 10th Annual 
ASUP Midyear Clinical Meeting, Washington, D.C., December 1975 
Fall & Spring Seminars, NECHP, 1975 and 1976, 11th Annual ASHP Midyear 
Clinical Meeting, Anaheim, California, December 1976 
124th APhA Annual Meeting, May 18, 1977 , New York City, 24th Annual Seminar 
New England Council of Hospital Pharmacists, Newport, Rhode Island, 
June 2-4, 1977 
12th Annual ASHP Midyear Clinical Meeting, Atlanta, Georgia, December 1977 
Research and Publications 
Contributing Author - Drug Information Publications, Yale-New Haven 
Hospital, 1975 - 1978 
Contributing Abstractor - International Pharmaceutical Abstracts, 1975 -
1976 
Charles D. Ponte and Edward L. Decker, "Leukopenia and Hepatotoxicity 
as a Possible Consequence of Chlorpromazine Administration," Drug 
Intelligence and Clinical Pharmacy, Vol. 10:562-565, (October) 1976. 
Co-Author - "Glyburide" (Sulfonylurea), with Bette Bennett, Medical Letter, 
June 18, 1976 
Co-Author - Patient Information Booklet for Cardiovascular Surgical Patients 
("When You Go Home"), Yale-New Haven Hospital, May 1978 
Co-Author - (unpublished) - "A Study of Medication Teaching Aids" 
by Gregory Gousse, Charles D. Ponte and Henry Palmer, 1977 
Author (Book Review) - Enteral Hyperalimentation with Chemically Defined 
Elemental Diets: A Source Book, by Dennis B. Worthen and Joan R. 
Lorimer. Published in the American Journal of Hospital Pharmacy Vol. 35, 
No. 6:749 (June) 1978. 
Pharm.D. Research Project - "Assessment of Pharmacist Medication Counseling 
of Hospitalized Patients" 
Charles D. Ponte, Arthur G. Lipman and C. Patrick Moran, "Use Review of 
Nutritionally Complete Liquid Diets," American Journal of Hospital Pharmacy 
Vol. 35:159-162, (February) 1978. 
Author (Book Review) - Enteral Hyperalimentation with Chemically Defined 
Elemental Diets: A Source Book (Second Edition); by Dennis B. 
Worthen et al, (awaiting publication in American Journal of Hospital 
Pharmacy, 1980) 
Manuscript in Progress - Review Article - "Metoclopramide" 
Awards and Honors 
Dean's List - Five Times 
Rho Chi Honor Society Recognition Certificate, 1971 
National Pharmaceutical Council/'SAPhA Pharmaceutical Industry Intern, 
Summer 1974 (Ortho Pharmaceutical Corp.) 
McKesson and Robbins Plaque, 1975 
Mortar and Pestle Society, 1975 
SAPhA Certificate of Recognition, 1975 
Peter Bookish Award, 1975 
Bristol Laboratories Award, 1975 
Who's Who in Connecticut, 1974 - 1975 
Who's Who Among Students in American Universities and Colleges, 1974-1975 
-7-
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Non-Professional Work Experience 
1969 - 1973 " Dot Fastener Co. , Waterbury, Connecticut 
(Summer Employment - Shipping Clerk, 
Dial Press and Islet Machine Operator) 
1971 - 1972 Laboratory Assistant - Botany and Micro-
biology (University of Connecticut, Waterbury 
Branch) 
Non-Professional Memberships 
Life Member - Amateur Trapshooting Association of America 
Bristol Fish and Game Club 
Connecticut Trapshooting Association 
Wo1co11 Landowners Protective Association 
Non-Professional Awards 
Sports Afield Distinguished Angler's Award, 1970 
Bristol Fish and Game Club, Trapshooting Champion, Class D, 1971 
Miscellaneous 
American National Red Cross Certification in Cardiopulmonary 
Resuscitation, 1976 
